W
WAVEMAN · COMPANY
SRZN · Surrozen, Inc./De
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

SRZN

Surrozen, Inc./DE
PHARMA & BIOTECH · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · CIK 0001824893
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-$977.8K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
47
13F, latest reported quarter
REVENUE GROWTH
-67.4%
XBRL, annual
NET MARGIN
-6960.8%
CONVERSIONS · 180D
3
codes C/M, not in net · no price filed
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$977.8K over 180 days
-$3.5M over 90 days · -$706.3K of it by a 10%+ holder
below 60% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
47 funds added or opened last quarter
below 56% of Pharma & Biotech
REVENUE
-67.4% year over year
below 87% of Pharma & Biotech
MARGIN
-6960.8% net margin
below 99% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$977.8K across 4 people in 180 days.
47 funds added or opened positions in the latest 13F quarter, of 79 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +84.7%
+84.7%12M
-8%+54%+115%+177%2025-092025-102025-122026-032026-052026-072026-09 2026-07-22 · TCG Crossover GP II, LLC sold $3.5M2025-11-13 · Kutzkey Tim bought $2.1M2025-11-13 · COLUMN GROUP III GP, LP bought $2.1M2025-11-13 · Kutzkey Tim bought $1.9M2025-11-13 · COLUMN GROUP III GP, LP bought $1.9M2026-03-24 · TCG Crossover Fund II, L.P. bought $1.3M2026-03-13 · TCG Crossover Fund II, L.P. bought $440.8K2026-03-13 · TCG Crossover Fund II, L.P. bought $440.8K2025-12-05 · Kutzkey Tim bought $320.1K2025-12-05 · COLUMN GROUP III GP, LP bought $320.1K2025-12-05 · Kutzkey Tim bought $283.4K2025-12-05 · COLUMN GROUP III GP, LP bought $283.4K2026-02-11 · TCG Crossover Fund II, L.P. bought $209.4K2026-02-11 · TCG Crossover Fund II, L.P. bought $209.4K2026-03-23 · TCG Crossover Fund II, L.P. bought $189.5K2026-03-23 · TCG Crossover Fund II, L.P. bought $189.5K2026-01-20 · Column Group Opportunity III GP, LP bought $187.5K2026-01-20 · Kutzkey Tim bought $187.5K2026-01-20 · Column Group Opportunity III GP, LP bought $166.3K2026-01-20 · Kutzkey Tim bought $166.3K2026-01-06 · COLUMN GROUP III GP, LP bought $159.2K2026-01-06 · Kutzkey Tim bought $159.2K2026-03-12 · TCG Crossover Fund II, L.P. bought $154.6K2026-05-04 · Parker Craig C sold $150.8K2026-01-06 · COLUMN GROUP III GP, LP bought $141.2K2026-01-06 · Kutzkey Tim bought $141.2K2026-01-13 · Kutzkey Tim bought $130.9K2026-01-13 · TCG Opportunity III GP, LLC bought $130.9K2026-01-15 · Column Group Opportunity III GP, LP bought $125.4K2026-01-15 · Kutzkey Tim bought $125.4K2026-01-13 · Kutzkey Tim bought $116.0K2026-01-13 · TCG Opportunity III GP, LLC bought $116.0K2026-01-15 · Column Group Opportunity III GP, LP bought $111.2K2026-01-15 · Kutzkey Tim bought $111.2K2026-05-04 · Williams Charles O sold $67.9K2026-01-14 · Kutzkey Tim bought $58.5K2026-01-14 · TCG Opportunity III GP, LLC bought $58.5K2026-05-04 · Li Yang sold $52.8K2026-01-14 · Kutzkey Tim bought $51.9K2026-01-14 · TCG Opportunity III GP, LLC bought $51.9K2025-12-04 · Kutzkey Tim bought $48.4K2025-12-04 · COLUMN GROUP III GP, LP bought $48.4K
INSIDER BUYINSIDER SELL
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows a net $977.8K sold by insiders over 180 days, 47 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Surrozen, Inc./DE insiders sold a net $977.8K of stock across 78 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
TCG Crossover GP II, LLC
—
SELL
2026-07-22
162,500.0
$3.5M
Li Yang
Exec. Vice President, Research
SELL
2026-05-04
1,584.0
$52.8K
Williams Charles O
Chief Operating Officer
SELL
2026-05-04
2,036.0
$67.9K
Parker Craig C
Chief Executive Officer
SELL
2026-05-04
4,524.0
$150.8K
TCG Crossover Fund II, L.P.
—
BUY
2026-03-24
53,329.0
$1.3M
78 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 73 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Column Group LLC
1,916,950.0 sh
$49.7M
TCG Crossover Management, LLC
1,473,101.0 sh
$38.2M
Boxer Capital Management, LLC
1,172,349.0 sh
$27.0M
Kalehua Capital Management LLC
770,356.0 sh
$20.0M
MILLENNIUM MANAGEMENT LLC
683,079.0 sh
$17.7M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
iShares Micro-Cap ETF
$356.2K POSITION · AS OF 2026-03-31
0.0%
1290 VT Micro Cap Portfolio
$26.3K POSITION · AS OF 2026-03-31
0.0%
TIFF MULTI-ASSET FUND
$35.9K POSITION · AS OF 2026-03-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$1.9M POSITION · AS OF 2026-03-31
0.0%
Fidelity Extended Market Index Fund
$743.0K POSITION · AS OF 2026-02-28
0.0%
Victory Extended Market Index Fund
$9.4K POSITION · AS OF 2026-04-30
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$2.8M
$4.8M
$1.4M
+140%
—
2024
$1.5M
$1.9M
$927.3K
+53%
—
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$3.5M$10.7M$0$12.5M
OPERATING INCOME$-42.1M$-25.5M$-45.8M$-44.3M
NET INCOME$-242.0M$-63.6M$-43.0M$-36.0M
EPS (DILUTED)-32.37-21.67-21.33-15.56
OPERATING CASH FLOW$-30.2M$-17.6M$-40.4M$-44.1M
CASH$89.2M$34.6M$36.0M$24.7M
BUYBACKS——$0$2.6M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →